FDANonrulemakingFDA-2021-D-0528
Who commented on this docket
Quantifying Sodium, Potassium, and Phosphorus in Labeling for Human Over-the-Counter and Prescription Drug Products; Draft Guidance for Industry; Availability
1 organizations filed 2 public comments on Quantifying Sodium, Potassium, and Phosphorus in Labeling for Human Over-the-Counter and Prescription Drug Products; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 1358d ago.
Organizations
1
Comments
2
RIN
—
Comment window
closed 1358d ago
Commenters (1)
- Consumer Healthcare Products Associationtrade assoc.2 filings · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.